These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17083565)

  • 1. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma.
    Domoto T; Miyama Y; Suzuki H; Teratani T; Arai K; Sugiyama T; Takayama T; Mugiya S; Ozono S; Nozawa R
    Cancer Sci; 2007 Jan; 98(1):77-82. PubMed ID: 17083565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
    Tölle A; Jung M; Lein M; Johannsen M; Miller K; Moch H; Jung K; Kristiansen G
    BMC Cancer; 2009 Jul; 9():248. PubMed ID: 19622156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
    Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
    Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma.
    Teratani T; Watanabe T; Kuwahara F; Kumagai H; Kobayashi S; Aoki U; Ishikawa A; Arai K; Nozawa R
    Cancer Lett; 2002 Jan; 175(1):71-7. PubMed ID: 11734338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
    Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
    Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
    Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.
    Xiao Y; Zhao H; Tian L; Nolley R; Diep AN; Ernst A; Fuh KC; Miao YR; von Eyben R; Leppert JT; Brooks JD; Peehl DM; Giaccia AJ; Rankin EB
    Cancer Res; 2019 Nov; 79(22):5758-5768. PubMed ID: 31585940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines.
    Takaoka N; Takayama T; Teratani T; Sugiyama T; Mugiya S; Ozono S
    BMC Mol Biol; 2011 Jul; 12():31. PubMed ID: 21771320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer.
    Christensen MV; Høgdall C; Jensen SG; Lokman N; Ricciardelli C; Christensen IJ; Christiansen P; Brask J; Karlsen MA; Nissen TK; Jochumsen KM; Høgdall E
    Anticancer Res; 2019 May; 39(5):2475-2482. PubMed ID: 31092442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
    Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
    Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
    Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
    Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma.
    Arai K; Iwasaki T; Sonoda A; Endo A
    Med Mol Morphol; 2020 Jun; 53(2):104-114. PubMed ID: 31728728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin II represents metastatic potential in clear-cell renal cell carcinoma.
    Ohno Y; Izumi M; Kawamura T; Nishimura T; Mukai K; Tachibana M
    Br J Cancer; 2009 Jul; 101(2):287-94. PubMed ID: 19513064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted expression of calcium-binding protein S100A5 in human kidney.
    Teratani T; Watanabe T; Yamahara K; Kumagai H; Ishikawa A; Arai K; Nozawa R
    Biochem Biophys Res Commun; 2002 Mar; 291(3):623-7. PubMed ID: 11855835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
    Yan Y; Yang FQ; Zhang HM; Che J; Zheng JH
    Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
    Yang J; Cheng TT; Wang LN; Chen W; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
    Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
    BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma.
    Kren L; Valkovsky I; Dolezel J; Capak I; Pacik D; Poprach A; Lakomy R; Redova M; Fabian P; Krenova Z; Slaby O
    Diagn Pathol; 2012 May; 7():58. PubMed ID: 22640987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.